The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
Official Title: A Randomized, Double-Blind, Vehicle Controlled, Parallel Group Study of the Dose-Response Profile of A-101 Topical Solution in Subjects With Seborrheic Keratosis.
Study ID: NCT02160626
Brief Summary: The main objective of this study is to evaluate the dose-response relationship of two concentrations of A-101 solution when applied to individual seborrheic keratosis (SK) lesions (target lesions) compared with a matching A-101 Solution Vehicle.
Detailed Description: The main objective of this study is to evaluate the dose-response relationship of two concentrations of A-101solution when applied to individual seborrheic keratosis (SK) lesions (target lesions) compared with a matching A-101 Solution Vehicle. Each subject will have 4 target lesions on the trunk/extremities. A further objective is to evaluate the safety and efficacy of two concentrations of A-101 solution and its matching vehicle when applied to SK target lesions on the trunk/extremities.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Gwinnett Clinical Research Center, Inc., Snellville, Georgia, United States
Michigan Center for Research Corp., Clinton Township, Michigan, United States
Oregon Medical Research Center, Portland, Oregon, United States
DermReseach, Inc., Austin, Texas, United States
The Education & Research Foundation, Inc., Lynchburg, Virginia, United States
Name: Jonathan S Weiss, MD
Affiliation: Gwinnett Clinical Research Center, Inc.
Role: PRINCIPAL_INVESTIGATOR
Name: Janet Dubois, MD
Affiliation: Derm Research, PLLC
Role: PRINCIPAL_INVESTIGATOR
Name: David C Wilson, MD
Affiliation: The Education & Research Foundation, Inc.
Role: PRINCIPAL_INVESTIGATOR
Name: Daniel M Stewart, DO
Affiliation: Michigan Center for Research Corp.
Role: PRINCIPAL_INVESTIGATOR
Name: Andrew Blauvelt, MD, MBA
Affiliation: Oregon Medical Research Center
Role: PRINCIPAL_INVESTIGATOR